Research ArticleOriginal Research
Variables Associated With Human Papillomavirus (HPV) Vaccine Acceptance by Men
Daron G. Ferris, Jennifer L. Waller, Jeremiah Miller, Pratik Patel, George A. Price, Lanier Jackson and Courtesia Wilson
The Journal of the American Board of Family
Medicine January 2009, 22 (1) 34-42; DOI: https://doi.org/10.3122/jabfm.2009.01.080008
Daron G. Ferris
MD
Jennifer L. Waller
PhD
Jeremiah Miller
Pratik Patel
George A. Price
Lanier Jackson
References
- ↵Villa LL, Costa RLR, Petta CA, et al. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16 and 18) L1 virus-like particle vaccine in young women: a randomized double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol 2005; 6: 271–78.
- The FUTURE II Study Group. Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N Engl J Med 2007; 356: 1915–27.
- The FUTURE II Study Group. Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3 and adenocarcinoma in situ. A combined analysis of four randomized clinical trials. Lancet 2007; 369: 1861–8.
- Garland SM, Hernandez-Avila M, Wheeler CM, et al. Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. N Engl J Med 2007; 356: 1928–43.
- ↵Nielson CM, Flores R, Harris RB, et al. Human papillomavirus prevalence and type distribution in male anogenital sites and semen. Cancer Epidemiol Biomarkers Prev 2007; 16: 1107–14.
- ↵Wiatrak BJ, Wiatrak DW, Broker TR, Lewis L. Recurrent respiratory papillomatosis: a longitudinal study comparing severity associated with human papilloma viral types 6 and 11 and other risk factors in a large pediatric population. Laryngoscope 2004; 114: 1–23.
- ↵
- ↵Abramowitz L, Benabderrahmane D, Ravaud P, et al. Anal squamous intraepithelial lesions and condyloma in HIV-infected heterosexual men, homosexual men and women: prevalence and associated factors. AIDS 2007; 21: 1457–65.
- Cupp MR, Malek RS, Goellner JR, Smith TF, Espy MJ. The detection of human papillomavirus deoxyribonucleic acid in intraepithelial, in situ, verrucous and invasive carcinoma of the penis. J Urol 1995; 154: 1024–9.
- Gregoire L, Cubilla AL, Reuter VE, Hass GP, Lancaster WD. Preferential association of human papillomavirus with high-grade histologic variants of penile-invasive squamous cell carcinoma. J Natl Cancer Inst 1995; 87: 1705–9.
- Palefsky JM, Holly EA, Ralston ML, Jay N, Berry JM, Darragh TM. High incidence of anal high-grade squamous intraepithelial lesions among HIV-positive and HIV-negative homosexual and bisexual men. AIDS 1998; 12: 495–503.
- Frish M, Glimelius B, van den Brule AJ, et al. Sexually transmitted infection as a cause of anal cancer. N Engl J Med 1997; 337: 1350–8.
- ↵Syrjanen S. Human papillomavirus (HPV) in head and neck cancer. J Clin Virol 2005; 32: S59–66.
- ↵D'Souza G, Kreimer AR, Viscidi R, et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 2007; 356: 1944–56.
- ↵Ferris DG, Waller JL, Owen A, Smith J. HPV vaccine acceptance among mid-adult women. J Am Bd Fam Med 2008; 21: 31–7.
- ↵Ferris DG, Waller JL, Owen A, Smith J. Mid adult women's attitudes about receiving the prophylactic human papillomavirus vaccine. J Lower Genital Tract Dis 2007; 11: 166–72.
- ↵Ferris DG, Waller JL, Miller J, et al. Men's attitudes toward receiving the HPV vaccine. J Lower Genital Tract Dis 2008; 12: 276–81.
- ↵Dunne EF, Nielson CM, Stone KM, Markowitz LE, Giuliano AR. Prevalence of HPV infection among men: a systematic review of the literature. J Infect Dis 2006; 194: 1044–57.
- ↵Wiley DJ, Wiesmeier E, Masongsong E, et al. Smokers at higher risk for undetected antibody for oncogenic human papillomavirus type 16 infection. Cancer Epidemiol Biomarkers Prev 2006; 15: 915–20.
- ↵McIntyre-Seltman K, Castle PE, Guido R, Schiffman M, Wheeler CM, ALTS Group. Smoking is a risk factor for cervical intraepithelial neoplasia grade 3 among oncogenic human papillomavirus DNA-positive women with equivocal or mildly abnormal cytology. Cancer Epidemiol Biomarkers Prev 2005; 14: 1165–70.
- ↵
- ↵
In this issue
The Journal of the American Board of Family
Medicine
Vol. 22, Issue 1
January-February 2009
Variables Associated With Human Papillomavirus (HPV) Vaccine Acceptance by Men
Daron G. Ferris, Jennifer L. Waller, Jeremiah Miller, Pratik Patel, George A. Price, Lanier Jackson, Courtesia Wilson
The Journal of the American Board of Family
Medicine Jan 2009, 22 (1) 34-42; DOI: 10.3122/jabfm.2009.01.080008
Variables Associated With Human Papillomavirus (HPV) Vaccine Acceptance by Men
Daron G. Ferris, Jennifer L. Waller, Jeremiah Miller, Pratik Patel, George A. Price, Lanier Jackson, Courtesia Wilson
The Journal of the American Board of Family
Medicine Jan 2009, 22 (1) 34-42; DOI: 10.3122/jabfm.2009.01.080008
Jump to section
Related Articles
- No related articles found.
Cited By...
- Human Papillomavirus (HPV) Vaccination Initiation and Completion Among Adult Males in the United States
- Human papillomavirus and vaccine-related perceptions among men who have sex with men: a systematic review
- HPV vaccine acceptability among men: a systematic review and meta-analysis
- Does Framing Human Papillomavirus Vaccine as Preventing Cancer in Men Increase Vaccine Acceptability?
- Human papillomavirus knowledge and vaccine acceptability among a national sample of heterosexual men
- Parental Acceptance of a Mandatory Human Papillomavirus (HPV) Vaccination Program
- Optimism: A Good Theme for Family Medicine